Amstel Pharma Private Limited

Amstel Pharma Private Limited - pharma in Thrissur, Kerala, India. FY 2026 financials & compliance.
CIN U24233KL2009PTC025014 Incorporated 13 November 2009 ROC Ernakulam HQ Thrissur, Kerala, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.56 Cr
▲ 20% YoY
Net profit · FY 2024
₹3.93 Lakh
Net margin 2.5%
EBITDA · FY 2024
₹5.81 Lakh
EBITDA margin 3.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Satisfied charges
₹22 Lakh
No open charges
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings

About Amstel Pharma Private Limited

Data last updated:

Amstel Pharma Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2009PTC025014. Its GSTIN is 32AAICA8204H1ZZ (Kerala).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Komattil Haridas and Koduvayur Anantharaman Viswanathan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2/1014 Pallath Lane East Poonkunnam, Thrissur, Kerala, India – 680002.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.56 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹3.93 Lakh (net margin 2.5%) and EBITDA of ₹5.81 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 7% over five years.

As per MCA filings, the company has satisfied charges of ₹22 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Amstel Pharma Private Limited
CIN U24233KL2009PTC025014
Registration Number 025014
Incorporation Date 13 November 2009
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    2/1014 Pallath Lane East Poonkunnam, Thrissur, Kerala, India – 680002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Amstel Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Amstel Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Amstel Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Amstel Pharma Private Limited

The main business activity of Amstel Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Amstel Pharma Private Limited FY 2024 filings available

Amstel Pharma Private Limited reported revenue of ₹1.56 Cr (up 20% YoY) for FY 2024.

Revenue · FY 2024
₹1.56 Cr ▲ 20%
Net profit · FY 2024
₹3.93 Lakh margin 2.5%
EBITDA · FY 2024
₹5.81 Lakh margin 3.7%

Compounded Annual Growth Rate (CAGR) of Amstel Pharma Private Limited

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 22%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 23%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 20% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Amstel Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹5.81 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹3.93 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Amstel Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.7%••••••••••••••••
Net Profit Margin2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amstel Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Amstel Pharma Private Limited

Amstel Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Unisam Biotech Private Limited₹1.57 Cr (FY 2025)••••••••11638.0%••••Ahmedabad, Gujarat, India
Parixam Pharmaceuticals Private Limited₹1.56 Cr (FY 2023)••••••••1127.0%••••Surat, Gujarat, India
Xander Pharmaceuticals Private Limited₹1.56 Cr (FY 2025)••••••••••••Perintalmanna, Kerala, India
Vivion Pharmaceuticals Private Limited₹1.56 Cr (FY 2025)••••••••15.0%••••Jaipur, Rajasthan, India
Mayapur Merchandise Private Limited₹1.56 Cr (FY 2025)••••••••-37.0%••••Kolkata, West Bengal, India
Amstel Pharma Private Limited this company₹1.56 Cr (FY 2024)••••••••20.0%••••Thrissur, Kerala, India
Gybes Sales Private Limited₹1.56 Cr (FY 2025)••••••••652.0%••••Kolkata, West Bengal, India
Asteroids Healthcare Private Limited₹1.56 Cr (FY 2024)••••••••5.0%••••Jaipur, Rajasthan, India
Ayansh Lifesciences Private Limited₹1.55 Cr (FY 2025)••••••••96.0%••••Akbarpur, Uttar Pradesh, India
Probik Advisors Private Limited₹1.55 Cr (FY 2025)••••••••16.0%••••New Panvel, Maharashtra, India
Relife Drugs Private Limited₹1.55 Cr (FY 2025)••••••••21.0%••••Lucknow, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Amstel Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Amstel Pharma Private Limited

Amstel Pharma Private Limited is audited by T.V.GANESA IYER AND CO for the financial year 2017.

NameStatusAppointment DateCessation Date
T.V.GANESA IYER AND COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Amstel Pharma Private Limited

Amstel Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Komattil HaridasDirector13 Nov 200916 Years 10 MonthsCurrent
Koduvayur Anantharaman ViswanathanDirector13 Nov 200916 Years 10 MonthsCurrent

Ownership and Shareholding of Amstel Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Amstel Pharma Private Limited

Open charges
None
Satisfied charges
₹22 Lakh
Breakdown by lending institutions
Syndicate Bank₹0.22 Cr
Latest charge details
DateLenderAmountStatus
07 Feb 2011Syndicate Bank₹22 LakhSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Amstel Pharma Private Limited

Employment history and EPFO contributions of people linked to Amstel Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Amstel Pharma Private Limited

Amstel Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Deepthy Arakulangarh ceased to be Additional Director on 31 Dec 2020.

AGM
Amstel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Amstel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Ceased
Deepthy Arakulangarh ceased to be Additional Director.
Ceased
Govindankutty Edaparambath Vibin ceased to be Director.
Charges
A charge registered on 07 Feb 2011 via Charge ID 10318986 with Syndicate Bank was fully satisfied on 03 Feb 2018.
Charges
A charge with Syndicate Bank amounted to Rs. 22.00 Lakh with Charge ID 10318986 was registered on 07 Feb 2011.
Appointed
Koduvayur Anantharaman Viswanathan was appointed as Director.
Appointed
Komattil Haridas was appointed as Director.
Incorporation
13 Nov 2009
Amstel Pharma Private Limited was registered on 13 Nov 2009 with Roc Ernakulam & aged 16 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Amstel Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Amstel Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Amstel Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Amstel Pharma Private Limited

Amstel Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAICA8204H1ZZKeralaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Amstel Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amstel Pharma Private Limited

Amstel Pharma is an active private limited company based in Thrissur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2009 (17+ years old) and is registered under CIN U24233KL2009PTC025014.

Amstel Pharma reported revenue of ₹1.56 Cr for FY 2024 (up 20% YoY).

Amstel Pharma has 2 current directors:

Amstel Pharma reported a net profit of ₹3.93 Lakh (net margin 2.5%) and EBITDA of ₹5.81 Lakh (EBITDA margin 3.7%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Amstel Pharma is 22% over three years and 7% over five years. In the latest year (FY 2024) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Amstel Pharma is 32AAICA8204H1ZZ, registered in Kerala.

The CIN (Corporate Identification Number) of Amstel Pharma is U24233KL2009PTC025014. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amstel Pharma was incorporated on 13 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ernakulam.

The peers of Amstel Pharma by revenue are Unisam Biotech Private Limited, Parixam Pharmaceuticals Private Limited, Xander Pharmaceuticals Private Limited, Vivion Pharmaceuticals Private Limited, Mayapur Merchandise Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Deepthy Arakulangarh ceased to be Additional Director on 31 Dec 2020. Govindankutty Edaparambath Vibin ceased to be Director on 30 Dec 2020. Koduvayur Anantharaman Viswanathan was appointed as Director on 13 Nov 2009. Amstel Pharma has 4 board changes on record in total.

The registered office of Amstel Pharma is at 21014 Pallath Lane East Poonkunnam, Thrissur, Kerala, India – 680002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available